Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Seattle Trademark Lawyer
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: Seattle Trademark LawyerSeattle Biotech Companies Fight Over Allegedly Similar Names
By Michael Atkins
Plaintiff’s and defendant’s logos
Plaintiff Mirina Corp. is a Seattle-based biotech firm.
Defendant Marina Biotech is a Bothell, Wash.-based biotech firm.
According to plaintiff’s complaint, both companies promote RNA-based therapeutic research and drug development services.
The complaint alleges that on July 22, defendant’s predecessor changed its company’s name to Marina Biotech. It states that plaintiff warned defendant that the name change would create a conflict with Mirina’s name, which plaintiff claims it started to use in August 2008.
The complaint says the dominant part of both names sounds the same and defendant’s use is likely to cause confusion with plaintiff’s use.
The case cite is Mirina Corp. v. Marina Biotech, No. 10-01322 (W.D. Wash.).
Full post as published by Seattle Trademark Lawyer on August 23, 2010 (boomark / email).
Network Solutions and ICANN
allegedly registers searched domain names to prevent others from selling and forces customers to pay expensive fees.
Seattle Mortgage Co Faces California Class Action
Seattle Mortgage Co Faces California Class Action
Hurricane Ike
Gulf Coast Residents Fight for Compensation
Daiso Seattle LLC
Toxic Lead Found in Children's Jewelry
Bayer CropScience AG
alleging farmers suffered economic losses after Bayer's biotech Liberty Link rice was released into the food supply and countries banned US rice.
Two Energy Companies Settle Whistleblower Qui Tam Suit
Two Energy Companies Settle Whistleblower Qui Tam Suit

Biotech/Pharma Companies Look to Market for Capital
Biotech/Pharma Lobbying Scoreboard - Third Quarter Update - Part II
VC CEO Believes Biotech Is Entering Golden Era
Are Biotech Companies Stymied In Dealing With Universities
BIO CEO Outlines Challenges for Obama Administration
Analyst Lists Five Biotech Companies to Watch








